New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2014
09:09 EDTMNKDMannKind price target raised to $15 from $12 at Brinson Patrick
Brinson Patrick raised its price target for MannKind shares to $15 citing the FDA Approval of Afrezza for diabetes. The firm says the labeling, REMS program, and post-marketing requirements exceeded its expectations. It keeps an Outperform rating on the stock.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
05:46 EDTMNKDStocks with implied volatility movement; AMZN MNKD
Subscribe for More Information
March 20, 2015
16:00 EDTMNKDOptions Update; March 20, 2015
Subscribe for More Information
March 18, 2015
09:32 EDTMNKDMannKind faces cash shortfall if $100M debt not settled, TheStreet says
Subscribe for More Information
March 16, 2015
11:20 EDTMNKDStocks with call strike movement; MNKD BBRY
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use